Delivery Order SPE2DB20D1109-SPE2DB24FP49K

Award Date 7/12/24
Potential Completion Date 7/15/24
Potential Value $2.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,702.32 firm-fixed-price delivery order is for the supply of NUCYNTA 75 MG tablets. The contract has an ultimate completion date of March 5, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,351.56 firm-fixed-price delivery order is for the supply of NUCYNTA 75 MG TABLET 100S, a pharmaceutical product, with a completion date of November 14, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a $6,204.73 Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of NUCYNTA TABS 100MG, a pharmaceutical product, and has an ultimate completion date of July 23, 2024. The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,670.14 delivery order is for the prescription medication NUCYNTA 75 MG TABLET 100S. The contract has an ultimate completion date of November 14, 2024 and is a firm fixed-price delivery order. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $2,671.39, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of NUCYNTA 75 MG TABLET 100S, a pharmaceutical product, with a completion date of February 2, 2024. This award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,340.56 firm fixed-price delivery order is for the supply of NUCYNTA 100 MG TABLETs (NSN 4567132251) with a period of performance through February 4, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $5,970.19 firm fixed-price delivery order provides the DLA with NUCYNTA TABS 50MG, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of February 19, 2025 and was awarded on February 18, 2025. This contract is part of a larger $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of NUCYNTA TABS 75MG to the Medical Supply Chain, a component of the Defense Logistics Agency (DLA). The $4,359.13 firm fixed-price delivery order contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 14, 2025, with a completion date of February 18, 2025. The contract is not designated as a set-aside and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is a Delivery Order with a Firm Fixed Price valued at $1,351.56. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, covers the supply of the pain medication Nucynta 75 mg tablets. The contract has a period of performance through November 5, 2024 and was not set aside for any specific business type. Amerisourcebergen holds a $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $3,361.66 firm fixed price delivery order is for the supply of NUCYNTA 75 mg tablets to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025,...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB24FP49K
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,703.12 firm fixed-price delivery order is for the supply of NUCYNTA 75 mg tablets. The contract has a completion date of July 15, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen's role as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems, is evident from the wide array of medical commodities covered under its federal contract awards.

Generated 2/27/25, 10:28 AM